Lipid Emulsion [EPC]

Lipid Emulsion [EPC] was reported 2642 times

Drugs of the Lipid Emulsion [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 PARENTERAL NUTRITION ASSOCIATED LIVER DISEASE 76 0.8539
1 FAT OVERLOAD SYNDROME 7 0.7778
2 FATTY ACID DEFICIENCY 32 0.3902
3 PRODUCT PROCESS CONTROL ISSUE 3 0.2500
4 LACTOBACILLUS TEST POSITIVE 4 0.1905
5 CEREBRAL MICROEMBOLISM 2 0.0909
6 MANUFACTURING PROCESS CONTROL PROCEDURE ISSUE 2 0.0690
7 AMEGAKARYOCYTIC THROMBOCYTOPENIA 1 0.0588
8 SCAR INFLAMMATION 2 0.0571
9 POSTHAEMORRHAGIC HYDROCEPHALUS 3 0.0517
10 VASCULAR ACCESS SITE OCCLUSION 4 0.0506
11 BACILLUS BACTERAEMIA 5 0.0459
12 MALASSEZIA INFECTION 3 0.0441
13 PANTOEA AGGLOMERANS INFECTION 3 0.0390
14 PREMATURE BABY DEATH 3 0.0366
15 PUNCTURE SITE ERYTHEMA 3 0.0349
16 APNOEA NEONATAL 9 0.0347
17 NEONATAL INFECTION 11 0.0318
18 MECONIUM ILEUS 2 0.0303
19 SLEEP DISORDER THERAPY 6 0.0303
20 GASTROINTESTINAL STOMA OUTPUT ABNORMAL 4 0.0276
21 APPENDICOLITH 10 0.0258
22 PRODUCT STERILITY LACKING 2 0.0238
23 NEONATAL CHOLESTASIS 2 0.0238
24 JAUNDICE ACHOLURIC 2 0.0227
25 GASTROINTESTINAL STOMA OUTPUT DECREASED 3 0.0213
26 ACQUIRED AMEGAKARYOCYTIC THROMBOCYTOPENIA 1 0.0208
27 BACILLUS TEST POSITIVE 2 0.0202
28 ALEXITHYMIA 1 0.0200
29 PULMONARY MICROEMBOLI 2 0.0198
30 GASTROINTESTINAL STOMA OUTPUT INCREASED 9 0.0192
31 LACTOBACILLUS INFECTION 3 0.0183
32 ANTI-MUELLERIAN HORMONE LEVEL DECREASED 1 0.0172
33 ADMINISTRATION SITE NODULE 1 0.0167
34 COPPER DEFICIENCY 2 0.0167
35 PRODUCT COMPOUNDING QUALITY ISSUE 6 0.0164
36 ANTACID THERAPY 2 0.0154
37 BACTEROIDES INFECTION 4 0.0153
38 PSEUDOHYPONATRAEMIA 2 0.0146
39 TOTAL BILE ACIDS INCREASED 2 0.0137
40 APPLICATION SITE EXTRAVASATION 1 0.0133
41 VASCULAR DEVICE OCCLUSION 4 0.0118
42 ADMINISTRATION SITE OEDEMA 1 0.0116
43 HYPERPYREXIA 49 0.0116
44 DEVICE RELATED SEPSIS 23 0.0114
45 BILE ACIDS INCREASED 2 0.0113
46 BACILLUS INFECTION 7 0.0111
47 BLOOD ZINC DECREASED 2 0.0110
48 KLEBSIELLA TEST POSITIVE 7 0.0108
49 MYELOCYTE COUNT INCREASED 2 0.0106
50 AORTIC BRUIT 1 0.0104
51 GASTROSTOMY TUBE SITE COMPLICATION 2 0.0100
52 VASCULAR DEVICE INFECTION 44 0.0097
53 DEVICE PROGRAMMING ERROR 3 0.0095
54 ANALGESIC THERAPY 3 0.0093
55 CITROBACTER INFECTION 4 0.0093
56 DRUG THERAPY 3 0.0088
57 HYPERTRIGLYCERIDAEMIA 51 0.0087
58 LARGE INTESTINAL ULCER HAEMORRHAGE 3 0.0086
59 PUNCTURE SITE PAIN 2 0.0086
60 FEEDING DISORDER NEONATAL 9 0.0086
61 ARRHYTHMIA NEONATAL 1 0.0081
62 ADMINISTRATION SITE PRURITUS 1 0.0078
63 MYOCARDIAL DEPRESSION 2 0.0078
64 DUMPING SYNDROME 2 0.0076
65 OVERGROWTH BACTERIAL 2 0.0074
66 PRODUCT PACKAGING CONFUSION 18 0.0074
67 NECROTISING ENTEROCOLITIS NEONATAL 3 0.0074
68 RETINOPATHY OF PREMATURITY 4 0.0072
69 DAIRY INTOLERANCE 2 0.0071
70 ANTICOAGULANT THERAPY 2 0.0070
71 DEVICE COMPUTER ISSUE 2 0.0067
72 BLOOD CREATINE DECREASED 2 0.0066
73 ENTEROBACTER BACTERAEMIA 2 0.0066
74 LOCAL ANAESTHETIC SYSTEMIC TOXICITY 7 0.0066
75 DEVICE RELATED BACTERAEMIA 2 0.0065
76 SEPSIS NEONATAL 5 0.0062
77 FUNGAL SEPSIS 5 0.0060
78 STOMA COMPLICATION 6 0.0059
79 GROWTH FAILURE 2 0.0058
80 GASTROINTESTINAL MICROORGANISM OVERGROWTH 2 0.0057
81 BILIRUBIN CONJUGATED INCREASED 13 0.0056
82 ELECTROCARDIOGRAM QRS COMPLEX SHORTENED 2 0.0052
83 CONGENITAL DIAPHRAGMATIC HERNIA 2 0.0051
84 CATHETER SITE EXTRAVASATION 2 0.0050
85 LYMPHANGITIS 4 0.0050
86 DEATH OF RELATIVE 2 0.0049
87 ABNORMAL CLOTTING FACTOR 1 0.0049
88 ANAPHYLACTOID REACTION 20 0.0049
89 SUPERFICIAL VEIN THROMBOSIS 4 0.0048
90 HYPERPHOSPHATAEMIA 10 0.0046
91 SHORT-BOWEL SYNDROME 3 0.0046
92 HYPERGLYCAEMIC HYPEROSMOLAR NONKETOTIC SYNDROME 5 0.0045
93 FEEDING INTOLERANCE 2 0.0044
94 DERMATITIS DIAPER 3 0.0042
95 ARRESTED LABOUR 1 0.0042
96 FAECAL VOLUME DECREASED 2 0.0042
97 DUODENAL STENOSIS 2 0.0041
98 TEMPERATURE INTOLERANCE 42 0.0041
99 COMA HEPATIC 3 0.0040
100 TACHYPNOEA 55 0.0040
101 AMINO ACID LEVEL INCREASED 3 0.0040
102 ADENOIDAL DISORDER 1 0.0038
103 FAECAL VOLUME INCREASED 2 0.0038
104 GASTROINTESTINAL STOMA COMPLICATION 6 0.0038
105 HYPERNATRAEMIA 19 0.0038
106 FAECAL VOMITING 2 0.0038
107 INCORRECT DRUG ADMINISTRATION RATE 16 0.0038
108 INFANTILE APNOEA 3 0.0037
109 STREPTOCOCCAL BACTERAEMIA 4 0.0037
110 ABDOMINAL WOUND DEHISCENCE 1 0.0037
111 ANTITHROMBIN III DECREASED 1 0.0037
112 EXTRAVASATION 15 0.0036
113 ABDOMINAL SEPSIS 3 0.0034
114 PRODUCT CONTAMINATION MICROBIAL 4 0.0034
115 BLOOD PHOSPHORUS INCREASED 9 0.0033
116 ANAL SQUAMOUS CELL CARCINOMA 1 0.0032
117 SUSPECTED TRANSMISSION OF AN INFECTIOUS AGENT VIA PRODUCT 4 0.0032
118 PHLEBITIS 16 0.0031
119 ENTEROCOCCUS TEST POSITIVE 2 0.0031
120 SPINAL CORD INFECTION 2 0.0031
121 GASTROINTESTINAL MUCOSAL DISORDER 2 0.0031
122 MATERNAL EXPOSURE DURING DELIVERY 3 0.0030
123 PEPTIC ULCER HAEMORRHAGE 2 0.0029
124 NUTRITIONAL CONDITION ABNORMAL 2 0.0029
125 FOETAL HYPOKINESIA 2 0.0029
126 ENTEROCOCCAL BACTERAEMIA 3 0.0028
127 FOETAL GROWTH RESTRICTION 17 0.0028
128 IMMUNISATION REACTION 2 0.0028
129 HODGKIN'S DISEASE 2 0.0028
130 PRODUCT NAME CONFUSION 3 0.0027
131 TUMOUR PSEUDOPROGRESSION 3 0.0027
132 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 14 0.0027
133 ANISOCORIA 1 0.0026
134 ALKALOSIS 1 0.0026
135 PANCREATITIS NECROTISING 6 0.0026
136 METAPNEUMOVIRUS INFECTION 2 0.0026
137 FUNGAEMIA 4 0.0025
138 BRONCHOPULMONARY DYSPLASIA 2 0.0025
139 ATYPICAL HAEMOLYTIC URAEMIC SYNDROME 2 0.0025
140 VASOPLEGIA SYNDROME 4 0.0024
141 ABORTION 7 0.0024
142 DYSPHORIA 12 0.0024
143 CHOLESTASIS 45 0.0023
144 DEVICE RELATED INFECTION 36 0.0023
145 BILIARY OBSTRUCTION 3 0.0023
146 CHILLS 270 0.0023
147 SENSATION OF PRESSURE 2 0.0023
148 PNEUMOPERITONEUM 4 0.0022
149 URINARY TRACT INFECTION ENTEROCOCCAL 2 0.0021
150 PROTHROMBIN TIME SHORTENED 3 0.0021
151 CATHETER SITE SWELLING 2 0.0021
152 AIR EMBOLISM 1 0.0021
153 BLOOD ALKALINE PHOSPHATASE DECREASED 2 0.0021
154 VASCULAR PAIN 2 0.0021
155 STAPHYLOCOCCAL SEPSIS 10 0.0020
156 PYURIA 2 0.0020
157 INTRAVENTRICULAR HAEMORRHAGE 5 0.0020
158 SYSTEMIC CANDIDA 5 0.0020
159 PRODUCT CONTAMINATION PHYSICAL 5 0.0020
160 APPETITE DISORDER 13 0.0020
161 ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT 5 0.0019
162 BLOOD PHOSPHORUS DECREASED 7 0.0019
163 SYSTOLIC DYSFUNCTION 2 0.0019
164 FEBRILE BONE MARROW APLASIA 8 0.0019
165 PRODUCT COMMINGLING 2 0.0019
166 AMAUROSIS FUGAX 2 0.0019
167 TROPONIN I INCREASED 3 0.0018
168 ENTEROBACTER INFECTION 3 0.0018
169 IRON DEFICIENCY 8 0.0018
170 TOXIC EPIDERMAL NECROLYSIS 27 0.0018
171 KLEBSIELLA SEPSIS 2 0.0018
172 BACTERAEMIA 21 0.0018
173 BLOOD FIBRINOGEN DECREASED 2 0.0018
174 PUPILS UNEQUAL 2 0.0017
175 CARBON DIOXIDE DECREASED 2 0.0017
176 RECTAL ULCER 2 0.0017
177 BLOOD TRIGLYCERIDES INCREASED 30 0.0017
178 CYTOMEGALOVIRUS TEST POSITIVE 3 0.0017
179 BLOOD CULTURE POSITIVE 5 0.0017
180 BODY TEMPERATURE ABNORMAL 3 0.0016
181 AMYLASE INCREASED 6 0.0016
182 HYPOPHOSPHATAEMIA 12 0.0016
183 STAPHYLOCOCCAL BACTERAEMIA 7 0.0016
184 FISTULA DISCHARGE 2 0.0016
185 ANION GAP 1 0.0016
186 INFUSION SITE IRRITATION 2 0.0016
187 ABDOMINAL WALL ABSCESS 1 0.0015
188 SKIN NECROSIS 8 0.0015
189 INTERCEPTED PRODUCT SELECTION ERROR 2 0.0015
190 BACTERIAL SEPSIS 5 0.0015
191 APLASIA 3 0.0015
192 HYPERLIPIDAEMIA 18 0.0015
193 HYPERLACTACIDAEMIA 4 0.0015
194 INJECTION SITE NECROSIS 3 0.0015
195 STOMA SITE DISCHARGE 4 0.0015
196 INFUSION SITE RASH 2 0.0015
197 ANASTOMOTIC LEAK 1 0.0014
198 MALNUTRITION 16 0.0014
199 STAPHYLOCOCCUS TEST POSITIVE 3 0.0014
200 BODY TEMPERATURE INCREASED 29 0.0014
201 ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE 2 0.0014
202 PNEUMATOSIS INTESTINALIS 4 0.0014
203 CEREBELLAR HAEMORRHAGE 2 0.0014
204 MENINGITIS BACTERIAL 2 0.0014
205 ACUTE GRAFT VERSUS HOST DISEASE IN LIVER 1 0.0014
206 GRAFT VERSUS HOST DISEASE 10 0.0014
207 BLOOD URIC ACID INCREASED 8 0.0014
208 ATROPHIC VULVOVAGINITIS 1 0.0014
209 ACUTE ABDOMEN 2 0.0014
210 BILIARY DILATATION 2 0.0014
211 GLUCOSE TOLERANCE IMPAIRED 8 0.0014
212 LIVER FUNCTION TEST INCREASED 29 0.0013
213 CHOLESTATIC LIVER INJURY 3 0.0013
214 MENTAL FATIGUE 2 0.0013
215 BLOOD LOSS ANAEMIA 3 0.0013
216 ANAPHYLACTIC SHOCK 34 0.0013
217 PARAINFLUENZAE VIRUS INFECTION 2 0.0013
218 STOMA SITE HAEMORRHAGE 2 0.0013
219 PUSTULE 3 0.0013
220 INTRA-ABDOMINAL HAEMORRHAGE 3 0.0013
221 HYPERBILIRUBINAEMIA 13 0.0013
222 TOTAL LUNG CAPACITY DECREASED 2 0.0013
223 ANAL ULCER 1 0.0012
224 OXYGEN THERAPY 2 0.0012
225 HYPERVOLAEMIA 6 0.0012
226 QUADRIPARESIS 2 0.0012
227 TONSILLAR HYPERTROPHY 2 0.0012
228 AMAUROSIS 1 0.0012
229 KLEBSIELLA INFECTION 6 0.0012
230 CANCER PAIN 3 0.0012
231 CATHETER SITE PAIN 3 0.0012
232 APNOEA 9 0.0012
233 PSEUDOMONAL SEPSIS 2 0.0011
234 JAUNDICE CHOLESTATIC 4 0.0011
235 CHEST DISCOMFORT 115 0.0011
236 WRONG DRUG ADMINISTERED 10 0.0011
237 HEPATIC CYTOLYSIS 14 0.0011
238 METABOLIC ACIDOSIS 35 0.0011
239 PNEUMONIA KLEBSIELLA 2 0.0011
240 MACULE 3 0.0011
241 CYANOSIS 17 0.0011
242 VENTRICULAR FIBRILLATION 12 0.0011
243 APPENDICITIS 10 0.0011
244 SMALL INTESTINAL PERFORATION 2 0.0011
245 MATERNAL EXPOSURE TIMING UNSPECIFIED 4 0.0011
246 BLOOD MAGNESIUM DECREASED 9 0.0010
247 HEPATIC MASS 2 0.0010
248 RHINOVIRUS INFECTION 4 0.0010
249 STRIDOR 3 0.0010
250 INFUSION SITE REACTION 3 0.0010
251 ANORECTAL DISORDER 2 0.0010
252 HYPERPHAGIA 4 0.0010
253 MYASTHENIA GRAVIS 8 0.0010
254 VITAMIN B12 DEFICIENCY 4 0.0010
255 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 5 0.0010
256 DRUG DISPENSING ERROR 15 0.0010
257 IMMUNE-MEDIATED HEPATITIS 2 0.0010
258 LIVER INJURY 24 0.0010
259 BODY TEMPERATURE FLUCTUATION 2 0.0010
260 PULSELESS ELECTRICAL ACTIVITY 4 0.0010
261 MULTIPLE ORGAN DYSFUNCTION SYNDROME 27 0.0010
262 ABDOMINAL ADHESIONS 3 0.0009
263 BLOOD LACTIC ACID INCREASED 5 0.0009
264 ESCHERICHIA URINARY TRACT INFECTION 4 0.0009
265 CATHETER SITE ERYTHEMA 2 0.0009
266 ACUTE MYELOID LEUKAEMIA RECURRENT 2 0.0009
267 BOWEL MOVEMENT IRREGULARITY 7 0.0009
268 BACTERIAL INFECTION 17 0.0009
269 LISTLESS 3 0.0009
270 ELECTROCARDIOGRAM ST SEGMENT DEPRESSION 2 0.0009
271 RETROPERITONEAL HAEMATOMA 2 0.0009
272 HYPOALBUMINAEMIA 7 0.0009
273 OLIGOHYDRAMNIOS 3 0.0009
274 PNEUMOCYSTIS JIROVECI PNEUMONIA 2 0.0009
275 PSEUDOMEMBRANOUS COLITIS 2 0.0009
276 LARGE INTESTINAL OBSTRUCTION 2 0.0009
277 PULMONARY HAEMORRHAGE 7 0.0009
278 RENAL COLIC 2 0.0009
279 DISTRIBUTIVE SHOCK 2 0.0009
280 VIITH NERVE PARALYSIS 3 0.0009
281 HYPOPNOEA 3 0.0009
282 ELECTROLYTE IMBALANCE 10 0.0009
283 STEVENS-JOHNSON SYNDROME 19 0.0009
284 BLOOD BILIRUBIN INCREASED 23 0.0009
285 ESCHERICHIA BACTERAEMIA 2 0.0008
286 GESTATIONAL DIABETES 4 0.0008
287 BLOOD UREA INCREASED 14 0.0008
288 WEIGHT ABNORMAL 2 0.0008
289 GASTROINTESTINAL OBSTRUCTION 2 0.0008
290 HEPATITIS CHOLESTATIC 5 0.0008
291 SINUS BRADYCARDIA 8 0.0008
292 HAEMATOLOGICAL INFECTION 2 0.0008
293 TRANSPLANT FAILURE 2 0.0008
294 IMMUNE-MEDIATED ENTEROCOLITIS 3 0.0008
295 RETROPERITONEAL HAEMORRHAGE 2 0.0008
296 VENOOCCLUSIVE LIVER DISEASE 4 0.0008
297 HYPERCALCAEMIA 10 0.0008
298 DEVICE INFUSION ISSUE 2 0.0008
299 BLOOD ALKALINE PHOSPHATASE INCREASED 20 0.0008
300 INFUSION SITE EXTRAVASATION 5 0.0008
301 VENOOCCLUSIVE DISEASE 2 0.0008
302 INFUSION SITE SWELLING 5 0.0008
303 CATHETER SITE INFECTION 3 0.0008
304 ACUTE RESPIRATORY DISTRESS SYNDROME 14 0.0008
305 TROPONIN INCREASED 6 0.0008
306 RESPIRATORY RATE INCREASED 7 0.0008
307 PATHOLOGICAL FRACTURE 4 0.0008
308 PYREXIA 272 0.0008
309 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 3 0.0008
310 ACIDOSIS 6 0.0008
311 CLAVICLE FRACTURE 3 0.0008
312 CARDIOPULMONARY FAILURE 3 0.0008
313 EPIGASTRIC DISCOMFORT 3 0.0008
314 COMPARTMENT SYNDROME 2 0.0008
315 ASPERGILLOSIS 1 0.0008
316 MULTIPLE ALLERGIES 6 0.0008
317 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 2 0.0008
318 RESPIRATORY ACIDOSIS 3 0.0008
319 LUNG OPACITY 2 0.0008
320 JAUNDICE 20 0.0007
321 CHEILITIS 4 0.0007
322 ASPHYXIA 6 0.0007
323 PRODUCT PREPARATION ERROR 15 0.0007
324 RASH MACULO-PAPULAR 16 0.0007
325 STREPTOCOCCAL INFECTION 4 0.0007
326 NECROSIS 4 0.0007
327 ASCITES 21 0.0007
328 FISTULA 8 0.0007
329 PAPULE 5 0.0007
330 ACUTE LYMPHOCYTIC LEUKAEMIA 2 0.0007
331 PRODUCT SUPPLY ISSUE 5 0.0007
332 ENTEROCOLITIS 4 0.0007
333 ESCHERICHIA SEPSIS 2 0.0007
334 COMPLICATION ASSOCIATED WITH DEVICE 10 0.0007
335 BILIARY COLIC 2 0.0007
336 GASTROINTESTINAL NECROSIS 2 0.0007
337 HYPERGLYCAEMIA 25 0.0007
338 EOSINOPHILIA 12 0.0007
339 WRONG PATIENT RECEIVED PRODUCT 2 0.0007
340 COLD SWEAT 12 0.0007
341 CYTOMEGALOVIRUS INFECTION REACTIVATION 3 0.0007
342 PALPITATIONS 79 0.0007
343 ATYPICAL PNEUMONIA 2 0.0007
344 NORMOCHROMIC NORMOCYTIC ANAEMIA 2 0.0007
345 CENTRAL VENOUS CATHETERISATION 2 0.0007
346 BLOOD PRESSURE SYSTOLIC DECREASED 3 0.0007
347 HAEMODYNAMIC INSTABILITY 5 0.0007
348 DRUG LEVEL ABOVE THERAPEUTIC 3 0.0007
349 HYPERTHERMIA 5 0.0007
350 INSURANCE ISSUE 10 0.0007
351 SHOCK 15 0.0007
352 ANTICOAGULATION DRUG LEVEL ABOVE THERAPEUTIC 1 0.0007
353 PRODUCT DISTRIBUTION ISSUE 6 0.0006
354 RENAL FUNCTION TEST ABNORMAL 3 0.0006
355 HEPATIC FUNCTION ABNORMAL 24 0.0006
356 DISSEMINATED INTRAVASCULAR COAGULATION 9 0.0006
357 SWELLING OF EYELID 4 0.0006
358 HEPATOCELLULAR INJURY 9 0.0006
359 BLOOD ALBUMIN DECREASED 5 0.0006
360 ORTHOPNOEA 2 0.0006
361 CARDIOGENIC SHOCK 9 0.0006
362 VENTRICULAR HYPOKINESIA 2 0.0006
363 AORTIC VALVE DISEASE 1 0.0006
364 ANTICONVULSANT DRUG LEVEL INCREASED 1 0.0006
365 ABDOMINAL DISTENSION 64 0.0006
366 FEELING COLD 17 0.0006
367 THROMBOSIS IN DEVICE 2 0.0006
368 HYPOGAMMAGLOBULINAEMIA 4 0.0006
369 BREATH SOUNDS ABNORMAL 3 0.0006
370 CORONAVIRUS INFECTION 4 0.0006
371 LYME DISEASE 2 0.0006
372 PALLOR 16 0.0006
373 OXYGEN SATURATION DECREASED 33 0.0006
374 HYPOPHAGIA 15 0.0006
375 HYPOKALAEMIA 27 0.0006
376 ENDOCARDITIS 3 0.0006
377 ECCHYMOSIS 4 0.0006
378 PERIPHERAL COLDNESS 8 0.0006
379 REGURGITATION 2 0.0006
380 ACUTE SINUSITIS 1 0.0006
381 GRANULOMA 2 0.0006
382 SEPTIC SHOCK 25 0.0006
383 AORTIC STENOSIS 2 0.0006
384 URINE OUTPUT DECREASED 5 0.0006
385 ACUTE RESPIRATORY FAILURE 11 0.0006
386 THROMBOPHLEBITIS 2 0.0006
387 FOOD CRAVING 3 0.0006
388 SMALL INTESTINAL OBSTRUCTION 7 0.0006
389 TUMOUR LYSIS SYNDROME 5 0.0006
390 NYSTAGMUS 3 0.0006
391 SEPSIS 63 0.0006
392 ASPARTATE AMINOTRANSFERASE INCREASED 30 0.0006
393 FIBRIN D DIMER INCREASED 2 0.0006
394 CEREBRAL HAEMORRHAGE 20 0.0006
395 HAEMOLYTIC ANAEMIA 5 0.0006
396 CHRONIC GRAFT VERSUS HOST DISEASE 2 0.0006
397 FOOD INTOLERANCE 2 0.0005
398 INTESTINAL ISCHAEMIA 3 0.0005
399 INTRACRANIAL PRESSURE INCREASED 3 0.0005
400 INTESTINAL PERFORATION 6 0.0005
401 PROTEIN TOTAL DECREASED 2 0.0005
402 CHOLECYSTITIS ACUTE 3 0.0005
403 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 9 0.0005
404 CHOLELITHIASIS 17 0.0005
405 FOOD ALLERGY 4 0.0005
406 RALES 3 0.0005
407 LIVER FUNCTION TEST ABNORMAL 15 0.0005
408 PRODUCT LABEL CONFUSION 3 0.0005
409 THROMBOTIC MICROANGIOPATHY 5 0.0005
410 FEELING OF BODY TEMPERATURE CHANGE 3 0.0005
411 WOUND SECRETION 2 0.0005
412 PNEUMONIA FUNGAL 2 0.0005
413 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 3 0.0005
414 BLOOD IRON DECREASED 6 0.0005
415 INFUSION RELATED REACTION 33 0.0005
416 HEPATIC FAILURE 15 0.0005
417 TRANSAMINASES INCREASED 11 0.0005
418 NEURALGIA 12 0.0005
419 SHOCK HAEMORRHAGIC 4 0.0005
420 GENERALISED OEDEMA 6 0.0005
421 INFUSION SITE ERYTHEMA 4 0.0005
422 CANDIDA INFECTION 8 0.0005
423 ALANINE AMINOTRANSFERASE INCREASED 29 0.0005
424 CIRCULATORY COLLAPSE 8 0.0005
425 POOR PERIPHERAL CIRCULATION 2 0.0005
426 PURULENT DISCHARGE 2 0.0005
427 LEFT VENTRICULAR HYPERTROPHY 2 0.0005
428 INFUSION SITE PAIN 6 0.0005
429 ABSCESS INTESTINAL 1 0.0005
430 OCULAR ICTERUS 2 0.0005
431 INTENTIONAL PRODUCT USE ISSUE 40 0.0005
432 PARONYCHIA 2 0.0005
433 GINGIVAL SWELLING 2 0.0005
434 PURPURA 4 0.0005
435 ILEUS PARALYTIC 2 0.0004
436 PANCREATITIS ACUTE 10 0.0004
437 STATUS EPILEPTICUS 5 0.0004
438 PNEUMONIA ASPIRATION 11 0.0004
439 EXPOSURE DURING PREGNANCY 27 0.0004
440 HYPOGLYCAEMIA 21 0.0004
441 CAESAREAN SECTION 5 0.0004
442 DEVICE OCCLUSION 6 0.0004
443 STAPHYLOCOCCAL INFECTION 14 0.0004
444 FEAR OF INJECTION 3 0.0004
445 BRADYCARDIA 22 0.0004
446 HUMERUS FRACTURE 2 0.0004
447 HAEMATURIA 14 0.0004
448 GAMMA-GLUTAMYLTRANSFERASE INCREASED 9 0.0004
449 INTENTIONAL OVERDOSE 26 0.0004
450 INJECTION SITE EXTRAVASATION 5 0.0004
451 HEPATIC ENZYME ABNORMAL 2 0.0004
452 HYPERAMMONAEMIA 2 0.0004
453 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 3 0.0004
454 BRAIN INJURY 4 0.0004
455 CYTOKINE RELEASE SYNDROME 8 0.0004
456 BLOOD CREATININE INCREASED 26 0.0004
457 ANAPHYLACTIC REACTION 22 0.0004
458 ABDOMINAL INFECTION 1 0.0004
459 HEPATITIS 10 0.0004
460 HYPONATRAEMIA 22 0.0004
461 AORTIC ARTERIOSCLEROSIS 1 0.0004
462 TRISMUS 2 0.0004
463 BRONCHOPULMONARY ASPERGILLOSIS 3 0.0004
464 PERIORBITAL OEDEMA 2 0.0004
465 MALABSORPTION 2 0.0004
466 ACCIDENTAL OVERDOSE 14 0.0004
467 TACHYCARDIA 34 0.0004
468 WEIGHT FLUCTUATION 4 0.0004
469 THROMBOCYTOPENIA 42 0.0004
470 ANIMAL BITE 1 0.0004
471 AREFLEXIA 1 0.0004
472 BLOOD SODIUM DECREASED 7 0.0004
473 HYDROCEPHALUS 2 0.0004
474 POLYURIA 3 0.0004
475 HICCUPS 3 0.0004
476 FAECALOMA 2 0.0004
477 NONSPECIFIC REACTION 2 0.0004
478 VENTRICULAR TACHYCARDIA 6 0.0004
479 RESPIRATORY DISTRESS 10 0.0004
480 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 1 0.0004
481 VOMITING 170 0.0004
482 ANAL HAEMORRHAGE 1 0.0004
483 HYPERHIDROSIS 46 0.0004
484 SKIN INFECTION 4 0.0004
485 BLOOD TEST ABNORMAL 5 0.0004
486 SINUS TACHYCARDIA 5 0.0004
487 INTERNAL HAEMORRHAGE 4 0.0003
488 PRODUCT CONTAINER ISSUE 3 0.0003
489 RASH GENERALISED 9 0.0003
490 MULTI-ORGAN FAILURE 6 0.0003
491 MOUTH SWELLING 2 0.0003
492 BLOOD PRESSURE DECREASED 23 0.0003
493 ADENOVIRUS INFECTION 1 0.0003
494 EYELID OEDEMA 4 0.0003
495 MUCOSAL INFLAMMATION 9 0.0003
496 HYPOXIA 12 0.0003
497 LUNG INFILTRATION 3 0.0003
498 ENERGY INCREASED 2 0.0003
499 GENERAL PHYSICAL HEALTH DETERIORATION 39 0.0003
500 GASTROINTESTINAL INFECTION 3 0.0003
501 PROTHROMBIN TIME PROLONGED 2 0.0003
502 RESPIRATORY DISORDER 10 0.0003
503 BLOOD POTASSIUM DECREASED 10 0.0003
504 PREMATURE BABY 10 0.0003
505 OROPHARYNGEAL DISCOMFORT 3 0.0003
506 INGUINAL HERNIA 2 0.0003
507 EATING DISORDER 7 0.0003
508 DERMATITIS ACNEIFORM 2 0.0003
509 PLEURAL EFFUSION 20 0.0003
510 DEPRESSED LEVEL OF CONSCIOUSNESS 13 0.0003
511 SCOLIOSIS 2 0.0003
512 SEIZURE 37 0.0003
513 HAEMATEMESIS 8 0.0003
514 PNEUMOTHORAX 5 0.0003
515 RECALLED PRODUCT ADMINISTERED 3 0.0003
516 INCREASED APPETITE 6 0.0003
517 SUPRAVENTRICULAR TACHYCARDIA 3 0.0003
518 HEART RATE INCREASED 31 0.0003
519 ENTERITIS 2 0.0003
520 PROCTALGIA 2 0.0003
521 HAEMOGLOBIN ABNORMAL 2 0.0003
522 HYPERCHOLESTEROLAEMIA 3 0.0003
523 ATELECTASIS 3 0.0003
524 PHARYNGEAL SWELLING 3 0.0003
525 INFLAMMATORY BOWEL DISEASE 3 0.0003
526 FLUSHING 31 0.0003
527 BODY TEMPERATURE DECREASED 3 0.0003
528 GENERALISED TONIC-CLONIC SEIZURE 5 0.0003
529 INABILITY TO AFFORD MEDICATION 3 0.0003
530 FEBRILE NEUTROPENIA 20 0.0003
531 CYTOMEGALOVIRUS INFECTION 5 0.0003
532 HYPOTONIA 3 0.0003
533 COAGULOPATHY 5 0.0003
534 PRODUCT ADMINISTRATION ERROR 6 0.0003
535 HYPOTHERMIA 3 0.0003
536 POSTOPERATIVE WOUND INFECTION 2 0.0003
537 WRONG PRODUCT ADMINISTERED 2 0.0003
538 ULCER HAEMORRHAGE 2 0.0003
539 EPILEPSY 9 0.0003
540 LIVER DISORDER 13 0.0003
541 NEPHROTIC SYNDROME 2 0.0003
542 APLASIA PURE RED CELL 1 0.0003
543 RESPIRATION ABNORMAL 2 0.0003
544 LARGE INTESTINE POLYP 2 0.0003
545 LARGE INTESTINE PERFORATION 2 0.0003
546 FORMICATION 2 0.0003
547 HUNGER 4 0.0003
548 ENCEPHALOPATHY 7 0.0003
549 DRUG ERUPTION 5 0.0003
550 RETCHING 6 0.0003
551 THIRST 5 0.0003
552 ALTERED STATE OF CONSCIOUSNESS 6 0.0003
553 LEUKOCYTOSIS 5 0.0003
554 ABDOMINAL PAIN 64 0.0003
555 RESPIRATORY FAILURE 20 0.0003
556 MOUTH HAEMORRHAGE 2 0.0003
557 OBSTRUCTIVE AIRWAYS DISORDER 3 0.0003
558 HYPERTENSIVE CRISIS 3 0.0003
559 HYDRONEPHROSIS 2 0.0003
560 CARDIAC ARREST 22 0.0003
561 CONTRAINDICATED PRODUCT ADMINISTERED 8 0.0003
562 POLLAKIURIA 11 0.0003
563 HEPATOCELLULAR CARCINOMA 2 0.0003
564 PROTEINURIA 5 0.0003
565 DYSPNOEA 148 0.0003
566 LIPASE INCREASED 2 0.0003
567 GASTRIC HAEMORRHAGE 3 0.0003
568 MUSCLE TWITCHING 6 0.0003
569 HAEMOLYSIS 2 0.0003
570 LOW DENSITY LIPOPROTEIN INCREASED 2 0.0003
571 NAUSEA 204 0.0003
572 ACUTE MYELOID LEUKAEMIA 4 0.0003
573 THERAPY PARTIAL RESPONDER 4 0.0003
574 SPLENOMEGALY 3 0.0003
575 SPINAL PAIN 3 0.0003
576 GASTROINTESTINAL INFLAMMATION 2 0.0003
577 ELECTROCARDIOGRAM ABNORMAL 2 0.0003
578 COVID-19 PNEUMONIA 3 0.0003
579 PRODUCT USE COMPLAINT 4 0.0003
580 ARRHYTHMIA 12 0.0003
581 ULCER 4 0.0003
582 GINGIVAL PAIN 2 0.0003
583 PRODUCT USE ISSUE 47 0.0002
584 DRUG INTOLERANCE 24 0.0002
585 NIGHT SWEATS 8 0.0002
586 ADRENAL INSUFFICIENCY 3 0.0002
587 NOCTURIA 3 0.0002
588 BLOOD POTASSIUM INCREASED 4 0.0002
589 BONE MARROW FAILURE 5 0.0002
590 DECUBITUS ULCER 2 0.0002
591 ABNORMAL FAECES 2 0.0002
592 ESCHERICHIA INFECTION 2 0.0002
593 PULMONARY EMBOLISM 23 0.0002
594 ILEUS 3 0.0002
595 OEDEMA 13 0.0002
596 LIVE BIRTH 2 0.0002
597 DERMATITIS ALLERGIC 3 0.0002
598 ABSCESS LIMB 1 0.0002
599 VITAMIN D DECREASED 2 0.0002
600 MYDRIASIS 3 0.0002
601 DEHYDRATION 31 0.0002
602 CARDIAC MURMUR 2 0.0002
603 COMA 11 0.0002
604 PYELONEPHRITIS 2 0.0002
605 RESPIRATORY SYNCYTIAL VIRUS INFECTION 2 0.0002
606 BLOOD PRESSURE INCREASED 35 0.0002
607 HYPERKALAEMIA 8 0.0002
608 BLOOD CALCIUM INCREASED 2 0.0002
609 LYMPHOCYTE COUNT DECREASED 4 0.0002
610 HYPOTENSION 45 0.0002
611 CARDIOTOXICITY 2 0.0002
612 FACIAL PAIN 2 0.0002
613 TREMOR 37 0.0002
614 ELECTROCARDIOGRAM QT PROLONGED 8 0.0002
615 ANAL INCONTINENCE 2 0.0002
616 GASTROENTERITIS VIRAL 4 0.0002
617 NEUTROPHIL COUNT DECREASED 9 0.0002
618 ANAEMIA 42 0.0002
619 IMPAIRED GASTRIC EMPTYING 3 0.0002
620 LEUKOPENIA 11 0.0002
621 C-REACTIVE PROTEIN INCREASED 8 0.0002
622 GINGIVAL BLEEDING 3 0.0002
623 PRODUCT AVAILABILITY ISSUE 5 0.0002
624 DECREASED APPETITE 51 0.0002
625 ABDOMINAL HERNIA 1 0.0002
626 ACUTE GRAFT VERSUS HOST DISEASE 1 0.0002
627 IRON DEFICIENCY ANAEMIA 2 0.0002
628 PERICARDIAL EFFUSION 5 0.0002
629 ACUTE KIDNEY INJURY 33 0.0002
630 AGRANULOCYTOSIS 4 0.0002
631 FLANK PAIN 2 0.0002
632 HYPOCALCAEMIA 4 0.0002
633 COLITIS 8 0.0002
634 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 2 0.0002
635 PANCREATITIS 11 0.0002
636 ERUCTATION 4 0.0002
637 CEREBRAL INFARCTION 5 0.0002
638 LUNG DISORDER 10 0.0002
639 COELIAC DISEASE 2 0.0002
640 APPLICATION SITE BURN 1 0.0002
641 DELIRIUM 7 0.0002
642 ABDOMINAL TENDERNESS 1 0.0002
643 PNEUMONIA 65 0.0002
644 INFECTION 29 0.0002
645 CARDIAC FAILURE 16 0.0002
646 TOXIC SKIN ERUPTION 2 0.0002
647 STOMATITIS 12 0.0002
648 FEEDING DISORDER 4 0.0002
649 TOOTH ABSCESS 2 0.0002
650 AMMONIA INCREASED 1 0.0002
651 FEELING HOT 12 0.0002
652 NEUTROPHIL COUNT INCREASED 2 0.0002
653 OVERDOSE 42 0.0002
654 MUSCULOSKELETAL CHEST PAIN 3 0.0002
655 RENAL DISORDER 9 0.0002
656 SWELLING 18 0.0002
657 PULMONARY HYPERTENSION 4 0.0002
658 TENDERNESS 2 0.0002
659 DRUG-INDUCED LIVER INJURY 6 0.0002
660 TRANSFUSION 2 0.0002
661 WEIGHT DECREASED 53 0.0002
662 BLOOD LACTATE DEHYDROGENASE INCREASED 3 0.0002
663 JOINT DISLOCATION 2 0.0002
664 RASH ERYTHEMATOUS 9 0.0002
665 ANORECTAL DISCOMFORT 1 0.0002
666 ANAL FISTULA 1 0.0002
667 EPISTAXIS 14 0.0002
668 ANAL FISSURE 1 0.0002
669 INTESTINAL OBSTRUCTION 7 0.0002
670 ANAL ABSCESS 1 0.0002
671 MUSCLE TIGHTNESS 3 0.0002
672 FREQUENT BOWEL MOVEMENTS 5 0.0002
673 THROAT TIGHTNESS 5 0.0002
674 CLOSTRIDIUM DIFFICILE INFECTION 4 0.0002
675 IRRITABILITY 11 0.0002
676 ASPIRATION 2 0.0002
677 GASTROINTESTINAL PAIN 2 0.0002
678 MELAENA 4 0.0002
679 MENTAL STATUS CHANGES 5 0.0002
680 FUNGAL INFECTION 6 0.0002
681 MEDICATION ERROR 10 0.0002
682 SKIN DISORDER 6 0.0002
683 HEPATOTOXICITY 4 0.0002
684 PRURITUS 69 0.0002
685 PANCYTOPENIA 10 0.0002
686 ORAL PAIN 4 0.0002
687 ANGIOPATHY 1 0.0002
688 UPPER GASTROINTESTINAL HAEMORRHAGE 3 0.0002
689 ACUTE PULMONARY OEDEMA 1 0.0002
690 FACE OEDEMA 3 0.0002
691 BLOOD CALCIUM DECREASED 2 0.0002
692 MITRAL VALVE INCOMPETENCE 2 0.0002
693 FLATULENCE 10 0.0002
694 MICTURITION URGENCY 2 0.0002
695 METASTASES TO LUNG 2 0.0002
696 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 9 0.0002
697 FOETAL EXPOSURE DURING PREGNANCY 14 0.0002
698 NEEDLE ISSUE 5 0.0002
699 BLOOD CHOLESTEROL INCREASED 8 0.0002
700 NEUROTOXICITY 3 0.0002
701 WHEEZING 10 0.0002
702 PRODUCT PRESCRIBING ERROR 4 0.0002
703 GASTROINTESTINAL DISORDER 15 0.0002
704 MUSCLE RIGIDITY 2 0.0002
705 GOUT 3 0.0002
706 MALIGNANT NEOPLASM PROGRESSION 17 0.0002
707 RASH 72 0.0002
708 SUICIDE ATTEMPT 10 0.0002
709 AGITATION 12 0.0002
710 TUBULOINTERSTITIAL NEPHRITIS 3 0.0002
711 NO ADVERSE EVENT 29 0.0002
712 PLATELET COUNT DECREASED 17 0.0002
713 DYSARTHRIA 6 0.0002
714 BRAIN OEDEMA 2 0.0002
715 BLOOD URINE PRESENT 3 0.0002
716 MUSCLE ATROPHY 2 0.0002
717 DIABETES MELLITUS 12 0.0002
718 FLUID RETENTION 8 0.0002
719 MATERNAL EXPOSURE DURING PREGNANCY 14 0.0002
720 WHITE BLOOD CELL COUNT INCREASED 6 0.0002
721 SLEEP DISORDER 11 0.0002
722 GASTROINTESTINAL HAEMORRHAGE 13 0.0002
723 METASTASES TO CENTRAL NERVOUS SYSTEM 2 0.0002
724 MALAISE 68 0.0002
725 UNRESPONSIVE TO STIMULI 4 0.0002
726 LACTIC ACIDOSIS 5 0.0002
727 INCORRECT DOSE ADMINISTERED BY DEVICE 4 0.0002
728 ASPERGILLUS INFECTION 1 0.0002
729 BEDRIDDEN 2 0.0002
730 ORAL CANDIDIASIS 2 0.0002
731 HAEMATOCRIT DECREASED 3 0.0002
732 BLOOD PRESSURE ABNORMAL 3 0.0002
733 LIP SWELLING 5 0.0001
734 URINARY RETENTION 5 0.0001
735 ATRIOVENTRICULAR BLOCK COMPLETE 1 0.0001
736 DIARRHOEA 96 0.0001
737 TOXICITY TO VARIOUS AGENTS 25 0.0001
738 TASTE DISORDER 3 0.0001
739 PNEUMONITIS 4 0.0001
740 HEPATIC ENZYME INCREASED 10 0.0001
741 ABNORMAL LOSS OF WEIGHT 1 0.0001
742 PRODUCT DOSE OMISSION ISSUE 43 0.0001
743 ILLNESS 15 0.0001
744 RESPIRATORY ARREST 4 0.0001
745 PERITONITIS 3 0.0001
746 HYPOMAGNESAEMIA 2 0.0001
747 HAEMOPTYSIS 4 0.0001
748 MASS 2 0.0001
749 ABDOMINAL DISCOMFORT 24 0.0001
750 MOUTH ULCERATION 3 0.0001
751 LYMPHOPENIA 2 0.0001
752 SEASONAL ALLERGY 2 0.0001
753 PARALYSIS 2 0.0001
754 CELLULITIS 7 0.0001
755 FAECES DISCOLOURED 3 0.0001
756 PULMONARY ARTERIAL HYPERTENSION 2 0.0001
757 APATHY 2 0.0001
758 INTENTIONAL PRODUCT MISUSE 12 0.0001
759 GASTROENTERITIS 2 0.0001
760 ASTHENIA 51 0.0001
761 URINARY INCONTINENCE 4 0.0001
762 DRUG EFFECT LESS THAN EXPECTED 2 0.0001
763 TOOTH DISORDER 3 0.0001
764 IMMUNODEFICIENCY 2 0.0001
765 HAEMORRHAGE INTRACRANIAL 2 0.0001
766 OSTEOPENIA 2 0.0001
767 OEDEMA PERIPHERAL 16 0.0001
768 RENAL IMPAIRMENT 11 0.0001
769 UPPER RESPIRATORY TRACT INFECTION 6 0.0001
770 LIMB DISCOMFORT 4 0.0001
771 LUNG INFECTION 2 0.0001
772 NERVOUS SYSTEM DISORDER 4 0.0001
773 ARTERIAL OCCLUSIVE DISEASE 1 0.0001
774 ABNORMAL BEHAVIOUR 5 0.0001
775 PREMATURE DELIVERY 2 0.0001
776 ATRIAL FLUTTER 1 0.0001
777 HYPOTHYROIDISM 4 0.0001
778 THROMBOSIS 10 0.0001
779 CHEST PAIN 23 0.0001
780 CONSTIPATION 27 0.0001
781 MYALGIA 21 0.0001
782 DRY MOUTH 10 0.0001
783 URINARY TRACT INFECTION 21 0.0001
784 OFF LABEL USE 107 0.0001
785 METASTASES TO BONE 2 0.0001
786 BACK PAIN 28 0.0001
787 HALLUCINATION 9 0.0001
788 ABDOMINAL PAIN LOWER 3 0.0001
789 HYPERSENSITIVITY 22 0.0001
790 HYPERTENSION 25 0.0001
791 RENAL FAILURE ACUTE 5 0.0001
792 PERIPHERAL SWELLING 18 0.0001
793 DRUG RESISTANCE 3 0.0001
794 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 3 0.0001
795 MUSCULOSKELETAL DISCOMFORT 2 0.0001
796 ANURIA 1 0.0001
797 CONDITION AGGRAVATED 35 0.0001
798 MENTAL DISORDER 5 0.0001
799 DISCOMFORT 7 0.0001
800 COVID-19 20 0.0001
801 EAR INFECTION 3 0.0001
802 DYSPEPSIA 11 0.0001
803 PULMONARY OEDEMA 5 0.0001
804 WEIGHT INCREASED 25 0.0001
805 MYELOSUPPRESSION 4 0.0001
806 OSTEOMYELITIS 2 0.0001
807 END STAGE RENAL DISEASE 2 0.0001
808 SKIN LESION 3 0.0001
809 RESTLESSNESS 4 0.0001
810 HAEMATOCHEZIA 6 0.0001
811 DYSURIA 4 0.0001
812 DIZZINESS 54 0.0001
813 INJECTION SITE MASS 4 0.0001
814 CONJUNCTIVITIS 2 0.0001
815 DYSGEUSIA 8 0.0001
816 HEPATIC STEATOSIS 2 0.0001
817 ERYTHEMA 22 0.0001
818 HEPATIC CIRRHOSIS 2 0.0001
819 PHOTOPHOBIA 2 0.0001
820 GASTRIC ULCER 2 0.0001
821 HAEMORRHAGE 11 0.0001
822 ANGINA PECTORIS 3 0.0001
823 PULMONARY FIBROSIS 2 0.0001
824 BLOOD GLUCOSE DECREASED 5 0.0001
825 HERNIA 2 0.0001
826 INTERSTITIAL LUNG DISEASE 5 0.0001
827 MUSCULOSKELETAL STIFFNESS 9 0.0001
828 ATRIAL FIBRILLATION 10 0.0001
829 BLOOD PRESSURE SYSTOLIC INCREASED 2 0.0001
830 HAEMORRHOIDS 2 0.0001
831 LOSS OF CONSCIOUSNESS 13 0.0001
832 SINUS DISORDER 2 0.0001
833 PRESCRIBED UNDERDOSE 2 0.0001
834 PREGNANCY 2 0.0001
835 SOMNOLENCE 20 0.0001
836 DEVICE BREAKAGE 4 0.0001
837 DEATH 84 0.0001
838 RIB FRACTURE 2 0.0001
839 PRODUCT USE IN UNAPPROVED INDICATION 24 0.0001
840 INJECTION SITE ERYTHEMA 12 0.0001
841 RHABDOMYOLYSIS 4 0.0001
842 UNDERDOSE 7 0.0001
843 NERVOUSNESS 5 0.0001
844 CARDIO-RESPIRATORY ARREST 4 0.0001
845 NEUTROPENIA 13 0.0001
846 URTICARIA 16 0.0001
847 DERMATITIS 2 0.0001
848 HEAD INJURY 3 0.0001
849 CYSTITIS 3 0.0001
850 JOINT INJURY 2 0.0001
851 HIP FRACTURE 3 0.0001
852 DISEASE PROGRESSION 11 0.0001
853 POOR QUALITY SLEEP 2 0.0001
854 DEEP VEIN THROMBOSIS 6 0.0001
855 INCORRECT PRODUCT ADMINISTRATION DURATION 2 0.0001
856 PRODUCT DISPENSING ERROR 2 0.0001
857 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 5 0.0001
858 ANGIOEDEMA 4 0.0001
859 RENAL FAILURE 12 0.0001
860 VIRAL INFECTION 3 0.0001
861 COLITIS ULCERATIVE 4 0.0001
862 RASH PAPULAR 2 0.0001
863 BLISTER 5 0.0001
864 TRANSIENT ISCHAEMIC ATTACK 3 0.0001
865 LOWER RESPIRATORY TRACT INFECTION 4 0.0001
866 CONVULSION 5 0.0001
867 LETHARGY 5 0.0001
868 HYPOAESTHESIA 13 0.0001
869 NEOPLASM PROGRESSION 3 0.0001
870 RASH MACULAR 3 0.0001
871 INJECTION SITE PAIN 26 0.0001
872 LYMPHADENOPATHY 3 0.0001
873 MENTAL IMPAIRMENT 2 0.0001
874 ILL-DEFINED DISORDER 5 0.0001
875 INJECTION SITE URTICARIA 2 0.0001
876 SYNCOPE 8 0.0001
877 INJECTION SITE SWELLING 6 0.0001
878 PAIN 48 0.0001
879 DEVICE ISSUE 7 0.0001
880 HAEMOGLOBIN DECREASED 8 0.0001
881 ANOREXIA 1 0.0001
882 INFLAMMATION 4 0.0001
883 SWELLING FACE 5 0.0001
884 RESPIRATORY TRACT INFECTION 2 0.0001
885 DISORIENTATION 3 0.0001
886 HEADACHE 47 0.0001
887 COUGH 21 0.0001
888 ABORTION SPONTANEOUS 3 0.0001
889 GASTROOESOPHAGEAL REFLUX DISEASE 6 0.0001
890 RASH PRURITIC 4 0.0001
891 WHITE BLOOD CELL COUNT DECREASED 8 0.0001
892 LIMB INJURY 2 0.0001
893 ACUTE HEPATIC FAILURE 1 0.0001
894 OSTEOPOROSIS 3 0.0001
895 ABDOMINAL PAIN UPPER 15 0.0001
896 DIVERTICULITIS 2 0.0001
897 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 13 0.0001
898 HOSPITALISATION 11 0.0001
899 PAIN IN JAW 2 0.0001
900 MUSCULAR WEAKNESS 8 0.0001
901 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 5 0.0001
902 INTERNATIONAL NORMALISED RATIO INCREASED 2 0.0001
903 RED BLOOD CELL COUNT DECREASED 2 0.0001
904 RECTAL HAEMORRHAGE 3 0.0001
905 DYSPHONIA 4 0.0001
906 SURGERY 4 0.0001
907 CONFUSIONAL STATE 11 0.0001
908 THROAT IRRITATION 3 0.0001
909 THERAPY NON-RESPONDER 3 0.0001
910 NEPHROLITHIASIS 3 0.0001
911 MUSCLE SPASMS 12 0.0001
912 DRUG ADMINISTRATION ERROR 2 0.0001
913 NASOPHARYNGITIS 12 0.0001
914 ANKLE FRACTURE 1 0.0001
915 CARDIAC DISORDER 6 0.0001
916 BONE DENSITY DECREASED 2 0.0001
917 PRODUCTIVE COUGH 3 0.0001
918 ABSCESS 1 0.0001
919 ASTHMA 7 0.0001
920 INCORRECT DOSE ADMINISTERED 14 0.0001
921 THERAPEUTIC RESPONSE SHORTENED 2 0.0001
922 AGGRESSION 3 0.0001
923 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 2 0.0001
924 SPEECH DISORDER 3 0.0001
925 CRYING 2 0.0001
926 PANIC ATTACK 2 0.0001
927 TREATMENT NONCOMPLIANCE 3 0.0001
928 ADVERSE EVENT 5 0.0001
929 NECK PAIN 3 0.0001
930 NEUROPATHY PERIPHERAL 5 0.0001
931 DYSKINESIA 2 0.0000
932 SINUSITIS 5 0.0000
933 SKIN EXFOLIATION 4 0.0000
934 RHINORRHOEA 3 0.0000
935 DEVICE DISLOCATION 2 0.0000
936 FEELING ABNORMAL 11 0.0000
937 DRUG INEFFECTIVE 60 0.0000
938 NEOPLASM MALIGNANT 3 0.0000
939 INFLUENZA 5 0.0000
940 INJECTION SITE PRURITUS 3 0.0000
941 PRODUCT QUALITY ISSUE 6 0.0000
942 PAIN IN EXTREMITY 13 0.0000
943 TINNITUS 2 0.0000
944 SKIN DISCOLOURATION 2 0.0000
945 BURNING SENSATION 3 0.0000
946 DYSPHAGIA 4 0.0000
947 FALL 14 0.0000
948 CONTUSION 4 0.0000
949 DRY EYE 2 0.0000
950 ECZEMA 2 0.0000
951 PARAESTHESIA 6 0.0000
952 DRUG INTERACTION 6 0.0000
953 INJECTION SITE BRUISING 3 0.0000
954 INJECTION SITE HAEMORRHAGE 3 0.0000
955 INSOMNIA 10 0.0000
956 PROSTATE CANCER 3 0.0000
957 TREATMENT FAILURE 3 0.0000
958 FATIGUE 28 0.0000
959 PRODUCT STORAGE ERROR 3 0.0000
960 BONE PAIN 2 0.0000
961 EMOTIONAL DISTRESS 4 0.0000
962 THERAPEUTIC RESPONSE DECREASED 2 0.0000
963 VERTIGO 2 0.0000
964 DRY SKIN 4 0.0000
965 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 6 0.0000
966 VISION BLURRED 4 0.0000
967 INJECTION SITE REACTION 2 0.0000
968 ARTHRALGIA 12 0.0000
969 DEVICE MALFUNCTION 2 0.0000
970 THERAPY INTERRUPTED 2 0.0000
971 BRONCHITIS 2 0.0000
972 HOT FLUSH 2 0.0000
973 UNEVALUABLE EVENT 2 0.0000
974 CHRONIC KIDNEY DISEASE 2 0.0000
975 ANXIETY 7 0.0000
976 VISUAL IMPAIRMENT 3 0.0000
977 ADVERSE DRUG REACTION 2 0.0000
978 DEPRESSION 5 0.0000
979 SUICIDAL IDEATION 2 0.0000
980 MEMORY IMPAIRMENT 3 0.0000
981 MIGRAINE 2 0.0000
982 GAIT DISTURBANCE 4 0.0000
983 RHEUMATOID ARTHRITIS 2 0.0000
984 JOINT SWELLING 2 0.0000
985 BLOOD GLUCOSE INCREASED 3 0.0000
986 AMNESIA 1 0.0000
987 ACNE 1 0.0000
988 ARTHRITIS 1 0.0000
989 CEREBROVASCULAR ACCIDENT 2 0.0000
990 MYOCARDIAL INFARCTION 2 0.0000
991 ACCIDENTAL EXPOSURE TO PRODUCT 1 0.0000
992 ALOPECIA 1 0.0000